Potassium Ion

Potassium Ion

SCHEMBL3757322

[K+].[NH-]O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1276416 0.75
Potassium Ion SCHEMBL23462131 0.50 CA4 (0.50)
Potassium Ion SCHEMBL23462032 0.50 CA4 (0.50)
Potassium Ion SCHEMBL23462037 0.50 CA4 (0.50)
Potassium Ion SCHEMBL23462233 0.50 CA4 (0.50)
Potassium Ion SCHEMBL23462275 0.50 CA4 (0.50)
Potassium Ion SCHEMBL23462274 0.50 CA4 (0.50)
Potassium Ion SCHEMBL23462130 0.50 CA4 (0.50)
Potassium Ion SCHEMBL23462098 0.50 CA4 (0.50)
Potassium Ion SCHEMBL23462035 0.50 CA4 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113480409-A Preparation method for preparing industrial ethanol from ethyl carboxylate 云南铜业股份有限公司 2021-10-08 CN claimed
CN-110639689-B Beneficiation method for comprehensively recovering rare earth, strontium and molybdenum from rare earth tailings 广东省资源综合利用研究所 2021-05-25 CN claimed
CN-110665632-B Method for comprehensively recovering molybdenum, lead, fluorine and rare earth from rare earth ore 广东省资源综合利用研究所 2021-03-16 CN claimed
CN-110665632-A Method for comprehensively recovering molybdenum, lead, fluorine and rare earth from rare earth ore 广东省资源综合利用研究所 2020-01-10 CN claimed
CN-110639689-A Beneficiation method for comprehensively recovering rare earth, strontium and molybdenum from rare earth tailings 广东省资源综合利用研究所 2020-01-03 CN claimed
CN-118234839-A Concentrated water-soluble powder detergents 达尔格化学有限责任公司 2024-06-21 CN disclosed
WO-2023084316-A1 CONCENTRATED WATER-SOLUBLE POWDER DETERGENT DAERG CHIMICA S.R.L. (IT) 2023-05-19 WO disclosed
CN-113480409-A Preparation method for preparing industrial ethanol from ethyl carboxylate 云南铜业股份有限公司 2021-10-08 CN disclosed
CN-113480409-A Preparation method for preparing industrial ethanol from ethyl carboxylate 云南铜业股份有限公司 2021-10-08 CN disclosed
CN-110639689-B Beneficiation method for comprehensively recovering rare earth, strontium and molybdenum from rare earth tailings 广东省资源综合利用研究所 2021-05-25 CN disclosed
CN-110665632-B Method for comprehensively recovering molybdenum, lead, fluorine and rare earth from rare earth ore 广东省资源综合利用研究所 2021-03-16 CN disclosed
CN-110665632-A Method for comprehensively recovering molybdenum, lead, fluorine and rare earth from rare earth ore 广东省资源综合利用研究所 2020-01-10 CN disclosed
CN-110639689-A Beneficiation method for comprehensively recovering rare earth, strontium and molybdenum from rare earth tailings 广东省资源综合利用研究所 2020-01-03 CN disclosed
US-7846963-B2 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2010-12-07 US disclosed
US-20070167486-A1 Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2007-07-19 US disclosed
EP-1461010-A2 HYDROXAMIC ACID AND ITS DERIVATIVES AS INHIBITORS OF MELANOCYTE TYROSINASE FOR TOPICAL SKIN LIGHTENERS Integriderm, Inc. (US) 2004-09-29 EP disclosed
US-20030199558-A1 Hydroxamic acid and its derivatives as inhibitors of melanocyte tyrosinase for topical skin lighteners INTEGRIDERM, INC. 2003-10-23 US disclosed
WO-2003057184-A2 HYDROXAMIC ACID AND ITS DERIVATIVES AS INHIBITORS OF MELANOCYTE TYROSINASE FOR TOPICAL SKIN LIGHTENERS INTEGRIDERM, INC. (US) 2003-07-17 WO disclosed
WO-2002066168-A1 IMPROVEMENTS IN OR RELATING TO FLOTATION AUSMELT LIMITED (AU) 2002-08-29 WO disclosed